Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02831439
What this trial is testing

A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care

Who this might be right for
Breast Cancer
Medical College of Wisconsin 400,415
Testing effectiveness (Phase 2)Study completedNCT00203502
What this trial is testing

Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Arkansas 40
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Not applicableUnknownNCT06238453
What this trial is testing

The Effect of Training Given by Whatsapp Application on Mamography Health Beliefs and Behaviors

Who this might be right for
Breast Cancer
Kemal Yaran 134
Not applicableLooking for participantsNCT06166953
What this trial is testing

The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled Study

Who this might be right for
Breast Cancer
Baskent University 38
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableNot Yet RecruitingNCT06110845
What this trial is testing

CLinical Evaluation Of a comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA)

Who this might be right for
Breast Cancer
The Leeds Teaching Hospitals NHS Trust 800
Not applicableStudy completedNCT05634395
What this trial is testing

Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment

Who this might be right for
Breast Cancer
Institut Curie 200
Testing effectiveness (Phase 2)Looking for participantsNCT04523857
What this trial is testing

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 44
Not applicableStudy completedNCT05086731
What this trial is testing

Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Emory University 33
Testing effectiveness (Phase 2)Ended earlyNCT00481845
What this trial is testing

Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
Stanford University 1
Large-scale testing (Phase 3)Study completedNCT00148057
What this trial is testing

Diet and Breast Cancer Prevention Trial

Who this might be right for
Breast Cancer
University Health Network, Toronto 4,695
Testing effectiveness (Phase 2)Study completedNCT01218529
What this trial is testing

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

Who this might be right for
Brain MetastasesLung TumorsBreast Tumors
Hellenic Cooperative Oncology Group 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT05203445
What this trial is testing

Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07560475
What this trial is testing

Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients

Who this might be right for
HER2positiveAdvanced Breast CancerHER2 + Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableLooking for participantsNCT06483477
What this trial is testing

Dermatitis During Adjuvant Irradiation for BREAst Cancer:

Who this might be right for
Breast Cancer Female
University Hospital Schleswig-Holstein 268
Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Not applicableStudy completedNCT00885612
What this trial is testing

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Who this might be right for
Breast Cancer
AstraZeneca 1,114
Not applicableStudy completedNCT00991653
What this trial is testing

Weight Fluctuation After Breast Cancer Treatment

Who this might be right for
Breast CancerWeight Gain
The Royal Bournemouth Hospital 250
Early research (Phase 1)Study completedNCT01077453
What this trial is testing

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

Who this might be right for
Healthy, no Evidence of DiseaseLobular Breast Carcinoma in Situ
National Cancer Institute (NCI) 112
Next Page